Skip to main content
Clinical Trials/ISRCTN39397064
ISRCTN39397064
Completed
未知

Comparative, double blind, controlled study of intra-articular hyaluronic acid (Hyalubrix®) injections versus local anaesthetic in osteoarthritis of the hip

Fidia Farmaceutici S.p.A. (Italy)0 sites42 target enrollmentFebruary 18, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Hip osteoarthritis
Sponsor
Fidia Farmaceutici S.p.A. (Italy)
Enrollment
42
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2009 results in https://pubmed.ncbi.nlm.nih.gov/20003205/ (added 30/12/2020)

Registry
who.int
Start Date
February 18, 2009
End Date
June 30, 2007
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fidia Farmaceutici S.p.A. (Italy)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged greater than 40 years, either sex
  • 2\. Ambulant without assistance
  • 3\. Hip OA by American College of Rheumatology (ACR) radiographic criteria
  • 4\. Baseline Visual Analogue Scale (VAS) score of greater than 4 cm
  • 5\. Persistence of hip pain for at least 1 month before baseline
  • 6\. Signed informed consent

Exclusion Criteria

  • 1\. Comorbidities (e.g. rheumatoid arthritis, avascular necrosis, fibromyalgia)
  • 2\. Infection around the injection site
  • 3\. Treatment with oral, parenteral, or IA steroids within 3 months
  • 4\. Use of anticoagulants or history of thrombocytopaenia
  • 5\. Allergy to local anaesthetics
  • 6\. History of adverse reaction to IA Hyalubrix®
  • 7\. Pending hip replacement surgery
  • 8\. Use of a purported OA disease modifying agent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A 12-week, randomised, double-blind study evaluating the effects of low-dose (10 mg) and high-dose (80 mg) atorvastatin on macrophage activity and carotid plaque inflammation as determined by ultra small super-paramagnetic iron oxide (USPIO) enhanced carotid magnetic resonance imaging (MRI)Carotid atherosclerosisCirculatory System
ISRCTN64894118GlaxoSmithKline (UK)40
Completed
Not Applicable
A multicentre, double blind, placebo controlled, randomised trial to evaluate the effectiveness of a one-day versus seven-day regimen of nitrofurantoin for the treatment of asymptomatic bacteriuria in pregnancyAsymptomatic Bacteriuria (ASB)Infections and InfestationsBacteriuria
ISRCTN11966080World Health Organization (WHO) (Switzerland)778
Completed
Phase 3
Is Hedrin® 4% lotion Dev 42 more effective than Hedrin® 4% lotion against head louse eggs?Head louse infestationInfections and InfestationsPediculosis and phthiriasis
ISRCTN10431107Thornton & Ross Ltd (UK)72
Completed
Phase 2
A randomised, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexate
ISRCTN49455679Academic Medical Center (AMC) (The Netherlands)191
Completed
Not Applicable
Rituximab versus cyclophosphamide in connective tissue disease-ILDInterstitial lung disease in people with severe connective tissue disease, including systemic sclerosis, idiopathic interstitial myopathy (including polymyositis/dermatomyositis) and mixed connective tissue diseaseRespiratory
ISRCTN16474148Royal Brompton & Harefield NHS trust104